| Institution | PI Name | Title |
|---|
| Alexion Antibody Technologies, Inc. | Katherine Bowdish | Human Antibody Therapeutics Against Anthrax |
| Attagene, Inc. | Sergei Makarov | Identification of TLR signaling network |
| Burnham Instititute | Alex Strongin | Structure-based Drug Design for Smallpox Therapy |
| Cerus Corporation | Thomas Dubensky | Psoralen-Killed, Metabolically-Active Anthrax Vaccine |
| Dana-Farber Cancer Institute | Wayne Marasco | Human Antibodies and Targeted Vaccines Against SARS-CoV |
| Diversa Corporation | Eileen Tozer | Therapeutic and Diagnostic Antibodies Against SARS |
| Harvard University | David Edwards | Inhaled Large Porous Particles for Treatment of MDR-TB |
| L2 Diagnostics, LLC | Raymond Koski | Recombinant Subunit West Nile Virus Vaccine Development |
| Massachusetts General Hospital | Ethan Lerner | G-protein coupled receptors for bioagent detection |
| Medarex, Inc. | Israel Lowy | Development of Fully Human mAbs as Anthrax Antitoxins |
| Northwestern University | Steven Wolinsky | Detection of Category A Pathogens by Gold Nanoparticles |
| Path - Prog/Appropriate Technology in hlth | Bernhard Weigl | A Multiplex, Point-of-Care Test for Enteric Pathogens |
| Scripps Research Institute | Kim Janda | Human Monoclonal IgG for Protection against Anthrax |
| United Biomedical, Inc. | Chang Wang | Synthetic Peptide SARS Coronavirus Diagnostic Kit |
| University of Arkansas Medical Scis, Little Rock | Xuming Zhang | Developing recombinant coronavirus vaccines for SARS |
| University of California, Irvine | Philip Felgner | Scanning B. pseudomallei proteome for vaccine antigens |
| University of California - Lawrnc Lvrmr Nat Lab | Mary McBride | A Multiplexed Diagnostic Platform for Bioagent Detection |
| Wadsworth Center | Pei-Yong Shi | Identifying inhibitors of West Nile and dengue viruses |
| Washington University | Andrew Pekosz | M2 peptide based vaccines against influenza |
| Wayne State University | Philip Cunningham | Anti-infectives that target bacterial ribosomes |
| Wistar University | Hildegund Ertl | Genetic Vaccine to Rabies Virus |